These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3992533)

  • 1. Antihemostatic and antithrombotic effects of capsaicin in comparison with aspirin and indomethacin.
    Wang JP; Hsu MF; Hsu TP; Teng CM
    Thromb Res; 1985 Mar; 37(6):669-79. PubMed ID: 3992533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihemostatic and antithrombotic effects of XC386.
    Wang JP; Hsu MF; Huang LJ
    Thromb Res; 1985 Aug; 39(4):501-10. PubMed ID: 4049328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hsien-ho-t'sao (Agrimonia pilosa) on experimental thrombosis in mice.
    Hsu MF; Young JH; Wang JP; Teng CM
    Am J Chin Med; 1987; 15(1-2):43-51. PubMed ID: 3687839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
    Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
    Sheu JR; Chao SH; Yen MH; Huang TF
    Thromb Haemost; 1994 Oct; 72(4):617-21. PubMed ID: 7878641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate.
    Kang WS; Lim IH; Yuk DY; Chung KH; Park JB; Yoo HS; Yun YP
    Thromb Res; 1999 Nov; 96(3):229-37. PubMed ID: 10588466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet and antithrombotic efficacy of SR 121787, a nonpeptide orally active GP IIb/IIIa antagonist, in rabbits: comparison with clopidogrel and aspirin.
    Hoffmann P; Bernat A; Savi P; Herbert JM
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):360-6. PubMed ID: 9300321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.
    Han BH; Suh DY; Yang HO; Park YH; Kang YH; Kim YC
    Arzneimittelforschung; 1994 Oct; 44(10):1122-6. PubMed ID: 7818584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet aggregation by 2-(p-chlorophenyl)-4-thiazoleacrylic acid (Wy-23,049)--comparison with acetylsalicylic acid.
    Fenichel RL; Dougherty JA; Alburn HE
    Biochem Pharmacol; 1974 Dec; 23(23):3273-82. PubMed ID: 4374215
    [No Abstract]   [Full Text] [Related]  

  • 11. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vintoperol on platelet aggregation and experimental thrombosis.
    Csomor K; Kárpáti E
    Arzneimittelforschung; 1994 Jan; 44(1):36-40. PubMed ID: 8135876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs.
    Ogawa T; Sugidachi A; Naganuma H; Asai F
    Thromb Res; 2000 Mar; 97(5):307-15. PubMed ID: 10709906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of aspirin and indomethacin on the platelet contractile wave.
    Gerrard JM; White JG
    Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some properties of mouse platelets.
    Rosenblum WI; Nelson GH; Cockrell CS; Ellis EF
    Thromb Res; 1983 May; 30(4):347-55. PubMed ID: 6412387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolism.
    Uckun FM; Vassilev A; Bartell S; Zheng Y; Mahajan S; Tibbles HE
    Leuk Lymphoma; 2003 Sep; 44(9):1569-77. PubMed ID: 14565661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of "anti-platelet" drugs on bleeding time and platelet aggregation in normal human subjects.
    Buchanan GR; Martin V; Levine PH; Scoon K; Handin RI
    Am J Clin Pathol; 1977 Sep; 68(3):355-9. PubMed ID: 331937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic effect of PMC, a potent alpha-tocopherol analogue on platelet plug formation in vivo.
    Hsiao G; Yen MH; Lee YM; Sheu JR
    Br J Haematol; 2002 Jun; 117(3):699-704. PubMed ID: 12028044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
    Li S; Shi Q; Liu G; Zhang W; Wang Z; Wang Y; Dai K
    J Appl Physiol (1985); 2010 May; 108(5):1241-9. PubMed ID: 20133435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.